Q2SBE7 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifani64kccn325emrxbde3r775jklxk7jvskgnyxfo6ifql4phqee/metadata.json
IPFS of structure file: 
bafybeicawgmrobd3vkpnsb7m46xlt5szprycyywfxp44pqidjitcypsha4/AF-Q2SBE7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x665CBc036828f0545913b4B24EA0229BB1e4F3f2
First NFT owner address (bech32): 
genesis1vewtcqmg9rc9gkgnkjeyagpznwc7fulj3rvrxp
Current NFT ID #450082 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
450082
Accession (UniProt):
Q2SBE7
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Hahella chejuensis (strain KCTC 2396)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2SBE7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2SBE7|SYL_HAHCH Leucine--tRNA ligase OS=Hahella chejuensis (strain KCTC 2396) OX=349521 GN=leuS PE=3 SV=1 MEELYHPKKVEQEAQKFWEETDAFKVDEEPGKEKFYCLSMFPYPSGKLHMGHVRNYTIGDVISRYQRMQGKNVLQPMGWDAFGLPAENAALKNNVAPAKWTYENIAYMKNQLKLLGFGYDWNRELATCRPEYYKWEQWFFTRLYEKGLVYKKMSTVNWDPVDETVLANEQVIDGKGWRSGAVVERREIPQWFIKITDYAEQLLNDLDKLENWPEQVKTMQRNWINKSEGVEFHFKLKDHDGDLQVYTTRPDTIMGVTYVAIAPQHPLALEAAASNPQLAKFLDECKNTKVAEADMATMEKRGMDTGFFVIHPLTNEPAPIWVANFVLMDYGSGAVMSVPGHDERDHEFALKYGLPIKQVISVIDADEVDIQEKAITEKGILVNSGEFTGMTSQEAFDAVAEKLTAMGIGEKKINYRLRDWGVSRQRYWGAPIPMMTQEDGTEVPVPLADLPVRLPEDVEMDGVKSPIKADPNWSKRSYNGQPATQETDTFDTFMESSWYYARFCCPNLESAMLDPAAANYWLPVDYYVGGIEHAILHLLYSRFFHKLLRDEGLVDSDEPFKKLLCQGMVIAETFYREDPSSKKTYFNPRDVRVELDTQGNSPKAFLIEDGQPVIIGPKEKMSKSKNNGVDPQELIDKYGADTVRLFTMFAAPPEQSLEWSESGVEGQHRFLRRLWKLVHTHVEKKGAAPLNVAELNETQRTLRRKTHETIKKMTDEFNHRMAINTGIAMVMELLNELSRFEDDSPQGLAVVQEALETAVLVLAPIVPHISHGLWRELGHEDVVMNAPWPQLDEKALEKDSIELVVQVNGKLRARIQAAASANKDELEKLAFDDENVQRFMEDKTVVKVIVVPGKLVNIVVK